Journals / Haseki Tıp Bülteni / 2010 / Cilt: 48 - Sayı: 4

Romatoid artritli hastalarda, akciğer tutulumunun serum anti-Ccp düzeyleri ve hastalık aktivitesi ile korelasyonu

Correlation of pulmonary involvement with serum anti-CCP antibodies and disease activity in patients with rheumatoid arthritis

Pages
142–145
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The disease activity determined by the DAS28 was significantly negatively correlated with pulmonary involvement (The Medical Bulletin of Haseki 2010; 48: 142-5)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Lung involvement substantially increases the morbidity and mortality rates in patients with rheumatoid arthritis (RA), thus, the early detection of lung involvement is essential for proper management.
📊
Key Findings & Data:The aim of this study was to determine the relationship between serum anti-CCP antibodies and disease activity score-28 (DAS28), using the Stanford Health Assessment Questionnaire (HAQ) in patients with RA, whose pulmonary involvement was detected by computed tomography (CT).
💡
Conclusion & Impact:Conclusion: The disease activity determined by the DAS28 was significantly negatively correlated with pulmonary involvement (The Medical Bulletin of Haseki 2010; 48: 142-5)
🔬Design:Survey & Empirical Study
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Lung involvement substantially increases the morbidity and mortality rates in patients with rheumatoid arthritis (RA), thus, the early detection of lung involvement is essential for proper management. Several recent reports revealed that anti-CCP is an important parameter in the early diagnosis of RA and is closely related with the extraarticular manifestations of the disease. The aim of this study was to determine the relationship between serum anti-CCP antibodies and disease activity score-28 (DAS28), using the Stanford Health Assessment Questionnaire (HAQ) in patients with RA, whose pulmonary involvement was detected by computed tomography (CT). Methods: According to the high-resolution CT findings, the patients were divided into two groups - with pulmonary involvement (24 patients), and without a pulmonary disease (25 patients). Results: Statistically significant association was not found between pulmonary involvement and anti-CCP antibodies. There was no significant correlation between pulmonary involvement and disease activity evaluated by the HAQ. Conclusion: The disease activity determined by the DAS28 was significantly negatively correlated with pulmonary involvement (The Medical Bulletin of Haseki 2010; 48: 142-5)

Özet

Amaç: Romatoid artritli hastalarda akci¤er tutulumu morbidite ve mortalite oranlarını önemli derecede etkiler. Bu nedenle, akci¤er tutulumunun erken dönemde saptanması ve tedavi modalitesinin düzenlenmesi gerekir. Son zamanlarda Anti-CCP’nin, erken romatoid artrit tanısındaki önemi ve romatoid artritin ekstraartiküler bulgularıyla iliflkisi gösterilmifltir. Bu çalıflmanın amacı romatoid artritli hastalarda bilgisayarlı tomografi ile belirlenen akci¤er tutulumunun, serum anti- CCP düzeyleri ve DAS 28, Stanford Sa¤lık De¤erlendirme Anketi ile belirlenen hastalık aktivitesi ile korelasyonunu belirlemektir. Yöntemler: Hastalar yüksek çözünürlüklü bilgisayarlı tomografi sonuçlarına göre akci¤er tutulumu olan (24 hasta) ve akci¤er tutulumu olmayan (25 hasta) fleklinde iki gruba ayrıldı. Bulgular: Sonuç olarak, akci¤er tutulumu ile serum anti-CCP düzeyleri arasında istatistiksel olarak anlamlı bir iliflki saptanmadı. Akci¤er tutulumu ile Stanford Sa¤lık De¤erlendirme Anketi ile belirlenen hastalık aktivitesi arasında anlamlı bir korelasyon saptanmadı. Sonuç: Akci¤er tutulumu ile DAS 28 ile belirlenen hastalık aktivitesi arasında anlamlı negatif bir korelasyon saptandı. (Haseki Tıp Bülteni 2010; 48: 142-5)

🔖

Cite This Article

ÇİLDAĞ, S., ŞENTÜRK, T., ÜNSAL, A., GÜLTEKİN, B. (2010). Romatoid artritli hastalarda, akciğer tutulumunun serum anti-Ccp düzeyleri ve hastalık aktivitesi ile korelasyonu. Haseki Tıp Bülteni, Cilt: 48 - Sayı: 4, 142–145. https://ajindex.com/articles/268025

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Kroot EJJA, de Jong BAW, Van Leeuwen MA et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000
  2. [Abstract] / [PDF] 2. Lutra HS. Extraarticular rheumatoid arthritis. In: Koopman WI (ed). Arthritis and Allied Conditions 14th ed. Lippincott Williams and Wilkins 2001
  3. Harris ED. Clinical features of rheumatoid arhritis. In: Ruddy S, Harris ED, Sledge CB (eds). Texbook of Rheumatology, 6th ed. Philadelphia: WB Saunders 2001
  4. Anaya JM, Diethelm L, Ortiz LA et al. Pulmonary involvement in rehumatoid arthritis. Semin Arthritis Rheum 1995
  5. [Abstract] / [PDF] 5. Schwarz MI. Pulmonary manifestations of the collogen vascular diseases. In: Fishman AP, Elias JA, Fishman JA, Grippi MA (eds). Fishman's pulmonary diseases and disorders Vol 1, 13 th ed. New York: The Mc Grow Hill Co 1998
  6. Van Boekel MA, Vossenaar ER, Van De Hoogen FH, Van Venroo WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivitiy and diagnostic value. Arthritis Res 2002
  7. [Abstract] / [Full Text] / [PDF] 7. Schellkens GA, Visser H, De Jong BAW et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing anti-cyclic citrullinated peptide. Arthritis Rheum 2000
  8. [Abstract] / [PDF] 8. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalance and mortality. Rheumatology Oxford 1999
  9. [Abstract] / [PDF] 9. Horton MR. Rheumatoid arthritis associated interstitiallung disease. Crit Rev Comput Tomogr 2004
  10. Chanin K, Vallefo-Manzur F, Sternbach GL, Fromm R, Varon J. Pulmonary manifestations of rheumatoid artritis. Hospital Physician 2001
  11. Turesson C, Jacobsson L, Bergstrom U. Extra-articularrheumatoid arthritis: prevalance and mortality. Rheumatology Oxford 1999
  12. [Abstract] / [PDF] 12. Hakala M. Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest 1988
  13. [Abstract] / [PDF] 13. Bas S, Perneger TV, Seitz M, Tiercy J-M, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, antikeratin antibodies and IgM rheumatoid factors. Rheumatology 2002
  14. [Abstract] / [Full Text] / [PDF] 14. Schellkens GA, Visser H, De Jong BAW et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing anticycli